Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1505 of 6351
-
Can a simple drug stop bleeding in stem cell patients?
Disease control Recruiting nowThis study employs a prospective, randomized, double-blind, placebo-controlled design. It aims to compare the efficacy of etamsylate versus placebo in preventing bleeding complications in patients with thrombocytopenia following hematopoietic stem cell transplantation.
Phase 3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New hope for pancreatic cancer: experimental drug combo enters human trials
Disease control Recruiting nowThis study is designed to evaluate the safety and efficacy of KN510713 in combination with mFOLFIRINOX in patients with locally advanced or metastatic pancreatic cancer. The study will be conducted in two parts: Part 1 (Dose-finding) and Part 2 (Dose expansion).
Phase 1/2 • Sponsor: New Cancer Cure-Bio Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New study tests best way to prevent second stroke in seniors with a hole in the heart
Disease control Recruiting nowPatent foramen ovale (PFO) is an important mechanism of embolic stroke of undetermined source (ESUS). Current guidelines recommend PFO closure for high-risk PFO in patients younger than 60 years, and a recent retrospective cohort study from Taichung Veterans General Hospital has …
Sponsor: Taichung Veterans General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for kids with tough brain tumors: gene therapy meets immunotherapy and radiation
Disease control Recruiting nowThis clinical trial is studying a drug called SGT-53 along with radiation and another drug called Nivolumab. It's for children with brain tumors that have come back, gotten worse, or didn't get better with earlier treatments. The main questions it aims to answer are: What is the…
Early phase 1 • Sponsor: Children's National Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New daily oral treatment aims to tame peanut allergy
Disease control Recruiting nowThis is a Phase 1/2 study to evaluate the safety and clinical activity of ENP-501 in non-peanut allergic (NPA) healthy participants and participants with an established peanut allergy (PA)
Phase 1/2 • Sponsor: N-Fold, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could probiotics be the key to lowering uric acid?
Disease control Recruiting nowThe overall aim of the project is to determine whether a daily intake of health-promoting bacteria, known as probiotics, with or without a dietary fiber, affects uric acid levels in individuals with elevated levels of uric acid in the blood (hyperuricemia). Additionally, the proj…
Sponsor: Örebro University, Sweden • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for celiac sufferers: drug targets gut damage despite strict diet
Disease control Recruiting nowThe main aim is to see how DONQ52 works to improve small intestinal damage and reduce celiac-related symptoms due to gluten exposure, in participants with celiac disease (CeD) attempting to maintain a gluten-free diet (GFD) in treated participants versus placebo controls.
Phase 2 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New hope for painful skin condition: experimental drug enters mid-stage trial
Disease control Recruiting nowThe purpose of this study is to assess efficacy, safety, pharmacokinetics and immunogenicity of subcutaneous SCT650C in patients with Moderate to Severe Hidradenitis Suppurativa
Phase 2 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New drug combo aims to free MDS patients from frequent blood transfusions
Disease control Recruiting nowThis is a single arm open-label Phase II trial of luspatercept and darbepoetin alfa in non-mutated SF3B1 , lower-risk, RBC transfusion dependent MDS participants with an endogenous erythropoietin (EPO) level \< 500 IU/L.
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
AI reads CT scans to tell old from new spine breaks
Diagnosis Not yet recruitingOsteoporotic vertebral compression fractures are common in older adults and may present as either acute or chronic fractures. Correctly distinguishing acute from chronic fractures is clinically important because treatment strategies and management decisions differ depending on fr…
Sponsor: Xin Fan • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
New device could spot dangerous brain pressure without needles
Diagnosis Not yet recruitingThe goal of this observational study is to evaluate the diagnostic accuracy of non-invasive intracranial pressure (ICP) and intracranial compliance (ICC) pulse morphology and associated parameters (such as the P2/P1 ratio and nTTP) obtained with the brain4care system for the scre…
Sponsor: Braincare USA Corp • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
New hope for Hard-to-Treat cancers? early trial of HMPL-A251 begins
Disease control Recruiting nowThis is a first-in-human (FIH), phase Ⅰ/Ⅱa, open-label, multicenter clinical study of HMPL-A251 monotherapy in adult participants with unresectable, advanced or metastatic HER2-expressing solid tumors.
Phase 1/2 • Sponsor: Hutchmed • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Can a VR headset make childbirth less painful?
Symptom relief CompletedThis study is designed to evaluate whether a virtual reality (VR) intervention can help reduce pain and anxiety and improve childbirth satisfaction among laboring women. Eligible participants will be randomly assigned to either a VR intervention group or a control group receivin…
Sponsor: Wan-Lin Pan • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Zapping the brain to ease Parkinson's slowness
Symptom relief Recruiting nowThis study investigates the use of patterned repetitive transcranial magnetic stimulation (prTMS) as an intervention for bradykinesia in Parkinson's Disease (PD). More specifically, the study aims to determine whether prTMS over the supplementary motor area (SMA) can reduce sever…
Sponsor: Danish Research Centre for Magnetic Resonance • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New immunotherapy combo targets High-Risk prostate cancer before and after surgery
Disease control CancelledThis Phase 2 clinical trial is testing a new immunotherapy combination (N-803, ETBX-071, M-CENK) for men with high-risk prostate cancer before and after prostate surgery. The goal is to see if this treatment improves cancer outcomes and is safe.
Phase 2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could 'Good' bacteria on your skin tame psoriasis? new trial aims to find out
Disease control Recruiting nowA growing body of evidence indicates that the pathogenesis of psoriasis may be closely linked to skin microbiome dysbiosis. Compared with healthy individuals, the composition and function of the skin microbiota in psoriasis patients exhibit significant alterations5,6. This microb…
Phase 2 • Sponsor: Shenzhen People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Could a little liver radiation boost cancer immunotherapy?
Disease control Recruiting nowThe purpose of this study is to see if adding Low-Dose Liver Radiation (LD-LRT) improves progression free survival (PFS). This study is for patients with either melanoma or non-small cell lung cancer (NSCLC), with liver metastases, and receiving immunotherapy.
Sponsor: Jordan Kharofa • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a 14-Day pill reverse stomach precancer?
Disease control Recruiting nowThis study is designed to test the use of Pyrvinium vs placebo as a treatment for gastric intestinal metaplasia with features associated with increased risk of cancer. Response will be determined by assessing the extent and quality of the gastric intestinal metaplasia before and …
Phase 2 • Sponsor: Katherine Garman • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Video game therapy shows promise for kids with cerebral palsy
Symptom relief Not yet recruitingCerebral Palsy (CP) accounts for approximately 0.9% of the global disease burden and affects 2.4-4% of children under 5 years old, with associated developmental and coordination impairments. Pediatric physical therapy aims to enhance independence and quality of life; however, mai…
Sponsor: Ziauddin University • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New 'Spot Delete' proton therapy aims to spare prostate cancer patients from bowel troubles
Symptom relief Recruiting nowThis purpose of this study is to examine the placement of proton spots during pencil beam scanning proton therapy for low and intermediate risk prostate cancer. The researchers will test a unique technique called "Spot Delete" to control the placement of spots during treatment pl…
Sponsor: Covenant Health Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC